CD200R1 and Parkinson disease: Taken together, our results show that the CD200-CD200R1 system is altered in the MPTP experimental model of PD, suggesting that the absence of CD200 leads to a more activated microglial phenotype and that CD200R1 activation may attenuate the progression of neuronal damage in PD.